| Bradley T Hall, DO | |
|
415 S 28th Ave, Hattiesburg, MS 39401 | |
| (601) 579-5459 | |
| (601) 268-5733 |
| Full Name | Bradley T Hall |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 24 Years |
| Location | 415 S 28th Ave, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386764132 | NPI | - | NPPES |
| 00921701 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Slidell Memorial Hospital | Slidell, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Ochsner Medical Center-hancock | Bay saint louis, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
Patients show modest yet meaningful gains in limb movement and an improved outlook on life years after suffering a stroke, a major clinical study has found. The paper, published online this week in the New England Journal of Medicine, provides the best evidence yet that stroke sufferers in a controlled study can regain limb movement long after an injury, through intensive therapy with specially trained personnel and newly created robotic aids.
A single enzyme. That is all the researchers behind a new study need to manipulate to prevent the feared Ebola virus from spreading. Because with the enzyme they also take away the virus' ability to copy itself and thus produce more virus particles and more infection.
The adolescent brain appears to be more responsive to nicotine's rewarding effects than the adult brain, a UC Irvine Transdisciplinary Tobacco Use Research Center (TTURC) animal study has found.
Beverage companies spent $1.04 billion to advertise sugary drinks and energy drinks in 2018, a 26% increase compared to 2013, according to Sugary Drinks FACTS 2020, a new report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
› Verified 6 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Patients show modest yet meaningful gains in limb movement and an improved outlook on life years after suffering a stroke, a major clinical study has found. The paper, published online this week in the New England Journal of Medicine, provides the best evidence yet that stroke sufferers in a controlled study can regain limb movement long after an injury, through intensive therapy with specially trained personnel and newly created robotic aids.
A single enzyme. That is all the researchers behind a new study need to manipulate to prevent the feared Ebola virus from spreading. Because with the enzyme they also take away the virus' ability to copy itself and thus produce more virus particles and more infection.
The adolescent brain appears to be more responsive to nicotine's rewarding effects than the adult brain, a UC Irvine Transdisciplinary Tobacco Use Research Center (TTURC) animal study has found.
Beverage companies spent $1.04 billion to advertise sugary drinks and energy drinks in 2018, a 26% increase compared to 2013, according to Sugary Drinks FACTS 2020, a new report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley T Hall, DO 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5459 | Bradley T Hall, DO 415 S 28th Ave, Hattiesburg, MS 39401 Ph: (601) 579-5459 |
News Archive
Patients show modest yet meaningful gains in limb movement and an improved outlook on life years after suffering a stroke, a major clinical study has found. The paper, published online this week in the New England Journal of Medicine, provides the best evidence yet that stroke sufferers in a controlled study can regain limb movement long after an injury, through intensive therapy with specially trained personnel and newly created robotic aids.
A single enzyme. That is all the researchers behind a new study need to manipulate to prevent the feared Ebola virus from spreading. Because with the enzyme they also take away the virus' ability to copy itself and thus produce more virus particles and more infection.
The adolescent brain appears to be more responsive to nicotine's rewarding effects than the adult brain, a UC Irvine Transdisciplinary Tobacco Use Research Center (TTURC) animal study has found.
Beverage companies spent $1.04 billion to advertise sugary drinks and energy drinks in 2018, a 26% increase compared to 2013, according to Sugary Drinks FACTS 2020, a new report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
› Verified 6 days ago
Dr. Frank Joseph Hux, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-268-5733 | |
Charles R Brent, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1212 South 28th Ave, Hattiesburg, MS 39402 Phone: 601-475-2430 | |
Gregory R Toczyl, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-579-5240 | |
Richard Elwood Clatterbuck, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-268-5733 | |
Dr. Kerry L Bernardo, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3688 Veterans Memorial Drive, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7400 Fax: 601-554-7499 | |
Dr. Michael W Lowry, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Hospital Dr W, Hattiesburg, MS 39402 Phone: 601-296-3000 Fax: 601-296-3001 |